Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.
DWS Health and Wellness C SUHCX
- NAV / 1-Day Return 24.28 / +0.08 %
- Total Assets 293.7 Mil
-
Adj. Expense Ratio
- Expense Ratio 2.090%
- Distribution Fee Level Above Average
- Share Class Type Level Load
- Category Health
- Investment Style Large Growth
- Min. Initial Investment 1,000
- Status Open
- TTM Yield —
- Turnover 27%
USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 10:17 PM GMT+0
Morningstar’s Analysis SUHCX
Will SUHCX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 49.9
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Eli Lilly and Co | 11.57 | 33.1 Mil | Healthcare |
UnitedHealth Group Inc | 9.21 | 26.3 Mil | Healthcare |
Merck & Co Inc | 4.73 | 13.5 Mil | Healthcare |
Boston Scientific Corp | 4.23 | 12.1 Mil | Healthcare |
Novo Nordisk A/S ADR | 4.15 | 11.9 Mil | Healthcare |
Thermo Fisher Scientific Inc | 3.76 | 10.7 Mil | Healthcare |
Johnson & Johnson | 3.48 | 10.0 Mil | Healthcare |
AbbVie Inc | 3.11 | 8.9 Mil | Healthcare |
Danaher Corp | 2.82 | 8.0 Mil | Healthcare |
Vertex Pharmaceuticals Inc | 2.80 | 8.0 Mil | Healthcare |